Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$18.25
Change (%) Stock is Up 1.64 (9.87%)
Volume510,994
Data as of 07/27/16 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
07/12/16
Download Documentation Corporate Presentation July 2016

Recent News

More >>
DateTitle 
06/22/16Heron Therapeutics Announces Appointment of Christian Waage to Board of DirectorsPrinter Friendly Version
06/15/16Heron Therapeutics to Present at the JMP Securities Life Sciences ConferencePrinter Friendly Version
05/05/16Heron Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate ProgressPrinter Friendly Version
04/18/16Heron Therapeutics Provides Update on FDA Review of SUSTOL® NDAPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.